Ratio Review: Analyzing Zai Lab Limited ADR (ZLAB)’s Price-to-Cash and Price-to-Free Cash Flow

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

After finishing at $18.19 in the prior trading day, Zai Lab Limited ADR (NASDAQ: ZLAB) closed at $17.78, down -2.25%. In other words, the price has decreased by -$2.25 from its previous closing price. On the day, 1.63 million shares were traded. ZLAB stock price reached its highest trading level at $19.15 during the session, while it also had its lowest trading level at $17.74.


Our goal is to gain a better understanding of ZLAB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.43 and its Current Ratio is at 4.63. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.01.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on December 14, 2023, initiated with a Overweight rating and assigned the stock a target price of $47.50.

On August 10, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $70.

On January 21, 2022, Macquarie started tracking the stock assigning a Outperform rating and target price of $64.Macquarie initiated its Outperform rating on January 21, 2022, with a $64 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 14 ’24 when Edmondson Frazor Titus III sold 10,000 shares for $21.33 per share. The transaction valued at 213,346 led to the insider holds 16,408 shares of the business.

Smiley Joshua L bought 3,000 shares of ZLAB for $64,200 on May 13 ’24. The insider now owns 31,684 shares after completing the transaction at $21.40 per share. On Apr 04 ’24, another insider, Reinhart Harald, who serves as the insider of the company, sold 2,105 shares for $15.67 each. As a result, the insider received 32,992 and left with 51,800 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZLAB now has a Market Capitalization of 1848746752 and an Enterprise Value of 17051883520. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.03 while its Price-to-Book (P/B) ratio in mrq is 2.27. Its current Enterprise Value per Revenue stands at 58.583 whereas that against EBITDA is -46.34.

Stock Price History:

Over the past 52 weeks, ZLAB has reached a high of $37.92, while it has fallen to a 52-week low of $13.48. The 50-Day Moving Average of the stock is 4.99%, while the 200-Day Moving Average is calculated to be -21.11%.

Shares Statistics:

The stock has traded on average 631.31K shares per day over the past 3-months and 659550 shares per day over the last 10 days, according to various share statistics. A total of 98.72M shares are outstanding, with a floating share count of 98.19M. Insiders hold about 0.54% of the company’s shares, while institutions hold 42.15% stake in the company. Shares short for ZLAB as of 1715731200 were 3277059 with a Short Ratio of 5.19, compared to 1713139200 on 4077667.

Most Popular